PERKii Targeted Release Probiotics has acquired ProGel Microgel Technology Pty Ltd in a Scrip for Scrip deal, enhancing its probiotic delivery capabilities.
Information on the Target
PERKii Targeted Release Probiotics, renowned for its innovative encapsulation technology, has successfully acquired ProGel Microgel Technology Pty Ltd in a strategic Scrip for Scrip deal. This acquisition further bolsters PERKii's market position by enhancing its capability to deliver effective health solutions through probiotics. The proprietary technology is designed to ensure that active probiotics survive the digestive process and reach the intestines, which maximizes their health benefits.
ProGel Microgel Technology Pty Ltd is recognized for its advancements in microgel formulations. This technology aligns perfectly with PERKii’s core mission of providing high-quality and efficacious probiotic products. The integration of ProGel's microgel capabilities with PERKii's existing technologies is expected to create synergies that will amplify the overall product efficacy and consumer appeal.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The probiotics industry has experienced significant growth and innovation in recent years, driven by increasing consumer awareness of gut health and its impact on overall well-
Similar Deals
DKSH → Noru Pharma's ear care brands
2022
Barwon Healthcare Property Fund → Two fully leased medical centres
2021
PERKii Targeted Release Probiotics
invested in
ProGel Microgel Technology Pty Ltd
in
in a Other deal